Latest news with #ApolloHospitalsEnterprise
Business Standard
2 hours ago
- Business
- Business Standard
Stock Alert: Apollo Hospitals, Nykaa, Tata Motors, Hero Motocorp, Vodafone Idea
Stocks to Watch: Apollo Hospitals Enterprise reported 53.5% jump in consolidated net profit to Rs 389.60 crore on 13.1% increase in revenue from operations to Rs 5,592.20 crore in Q4 FY25 over Q4 FY24. FSN E-Commerce Ventures (Nykaa)s consolidated net profit surged 192.6% to Rs 20.28 crore on 23.6% jump in revenue from operations to Rs 2,061.76 crore in Q4 FY25 over Q FY24. Rama Steel Tubes has reported 3.9% fall in consolidated net profit to Rs 6.84 crore despite a 9.3% increase in revenue from operations to Rs 293.13 crore in Q4 FY25 as compared with Q4 FY24. IRCON International said that it has received an engineering, procurement, and construction (EPC) contract from the East Central Railway, Indian Railway, worth Rs 1,068.34 crore. Titagarh Rail Systems reported 18.36% decline in consolidated net profit to Rs 64.45 crore on 4.45% fall in revenue from operations to Rs 1,005.57 crore in the quarter ended 31 March 2025 over the quarter ended 31 March 2024. Genesys International Corporation reported 27.60% jump in consolidated net profit to Rs 18.95 crore on 32.30% surge in revenue from operations to Rs 94.16 crore in Q4 FY25 over Q4 FY24. Vodafone Ideas consolidated net loss narrowed to Rs 7,166.10 crore in Q4 FY25 compared with Rs 7,674.60 crore in Q4 FY24. Net sales increased 3.6% YoY to Rs 10,950 crore in Q4 FY25. Hero Motocorp's total sales increased 1.92% to 5,07,701 units in May 2025 compared with 4,98,123 units sold in May 2024. Tata Motors total sales fell 8.57% to 70,187 units in May 2025 as against 76,766 units sold in May passenger vehicle (including EV) fell 11% YoY to 42,040 units in May 2025.
Time of India
5 hours ago
- Business
- Time of India
Apollo Hospitals shares in focus after Q4 profit jumps 53% YoY to Rs 390 crore
Apollo Hospitals Enterprise shares will be in focus on Monday after the company reported a 53.5% year-on-year (YoY) jump in net profit for the March quarter. Net profit rose to Rs 390 crore in Q4FY25 from Rs 254 crore in the same quarter last year, beating Street estimates of Rs 374 crore. Revenue from operations grew 13% YoY to Rs 5,592 crore, compared to Rs 4,944 crore in Q4FY24. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Realize seu sonho de ter uma hidromassagem em casa Brasil Banheiras Saiba Mais Undo On a sequential basis, profit after tax (PAT) rose 5% from Rs 372 crore in Q3FY25. Revenue was marginally higher by 1.2% compared to Rs 5,527 crore in the previous quarter. Total expenses during the quarter stood at Rs 5,148 crore, up from Rs 5,060 crore in Q3FY25 and Rs 4,612 crore in Q4FY24. Key expenditure heads included cost of materials consumed, changes in inventories, employee benefits, and finance costs. The company's board has recommended a final dividend of Rs 10 per equity share for FY25. The record date for determining eligible shareholders has been set for August 19, 2025. Live Events Also Read: India's top 10 priciest stocks in 2025: MRF to Elcid, see who tops the list Segment revenue The company's revenue comes from healthcare services, retail health & diagnostics and digital health & pharmacy distribution. - Healthcare services: Q4FY25 revenue stood at Rs 2,843 crore versus Rs 2,803 crore in Q3FY25 and Rs 2,579 crore in Q4FY24. - Retail Health & Diagnostics: Q4FY25 revenue stood at Rs 394 crore versus Rs 390 crore in Q3FY25 and Rs 354 crore in Q4FY24. - Digital health & pharmacy distribution: Q4FY25 revenue stood at Rs 2,376 versus Rs 2,352 crore in Q3FY25 and Rs 2,027 crore in Q4FY24. The company also announced significant expansion in Bengaluru in the Sarjapur micro-market through the addition of 700 beds in 2 stages, to establish a dominant presence in the South-Eastern part of the city with a large addressable market. Also Read: Ola Electric, Kalyan Jewellers among 10 firms where promoters pledge increased in Q4 Apollo Hospitals share price target According to Trendlyne, the average target price for Apollo Hospitals stands at Rs 7,779, indicating a potential upside of nearly 13% from current levels. Among the 29 analysts tracking the stock, the consensus rating is 'Buy'. Apollo Hospitals shares are down 7% year-to-date but have gained 14% over the past three months. The company's market capitalisation currently stands at Rs 98,897 crore. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
Economic Times
6 hours ago
- Business
- Economic Times
Apollo Hospitals shares in focus after Q4 profit jumps 53% YoY to Rs 390 crore
Apollo Hospitals Enterprise shares will be in focus on Monday after the company reported a 53.5% year-on-year (YoY) jump in net profit for the March quarter. Net profit rose to Rs 390 crore in Q4FY25 from Rs 254 crore in the same quarter last year, beating Street estimates of Rs 374 crore. ADVERTISEMENT Revenue from operations grew 13% YoY to Rs 5,592 crore, compared to Rs 4,944 crore in Q4FY24. On a sequential basis, profit after tax (PAT) rose 5% from Rs 372 crore in Q3FY25. Revenue was marginally higher by 1.2% compared to Rs 5,527 crore in the previous quarter. Total expenses during the quarter stood at Rs 5,148 crore, up from Rs 5,060 crore in Q3FY25 and Rs 4,612 crore in Q4FY24. Key expenditure heads included cost of materials consumed, changes in inventories, employee benefits, and finance company's board has recommended a final dividend of Rs 10 per equity share for FY25. The record date for determining eligible shareholders has been set for August 19, 2025. Also Read: India's top 10 priciest stocks in 2025: MRF to Elcid, see who tops the list ADVERTISEMENT The company's revenue comes from healthcare services, retail health & diagnostics and digital health & pharmacy distribution.- Healthcare services: Q4FY25 revenue stood at Rs 2,843 crore versus Rs 2,803 crore in Q3FY25 and Rs 2,579 crore in Q4FY24. ADVERTISEMENT - Retail Health & Diagnostics: Q4FY25 revenue stood at Rs 394 crore versus Rs 390 crore in Q3FY25 and Rs 354 crore in Q4FY24.- Digital health & pharmacy distribution: Q4FY25 revenue stood at Rs 2,376 versus Rs 2,352 crore in Q3FY25 and Rs 2,027 crore in Q4FY24. ADVERTISEMENT The company also announced significant expansion in Bengaluru in the Sarjapur micro-market through the addition of 700 beds in 2 stages, to establish a dominant presence in the South-Eastern part of the city with a large addressable market. Also Read: Ola Electric, Kalyan Jewellers among 10 firms where promoters pledge increased in Q4 ADVERTISEMENT According to Trendlyne, the average target price for Apollo Hospitals stands at Rs 7,779, indicating a potential upside of nearly 13% from current levels. Among the 29 analysts tracking the stock, the consensus rating is 'Buy'.Apollo Hospitals shares are down 7% year-to-date but have gained 14% over the past three months. The company's market capitalisation currently stands at Rs 98,897 crore. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)
Reuters
3 days ago
- Business
- Reuters
India's Apollo Hospitals beats profit estimates on high demand for healthcare services
HYDERABAD, May 30 (Reuters) - India's Apollo Hospitals Enterprise ( opens new tab reported fourth-quarter profit above market estimates on Friday, driven by higher demand for its healthcare services. The hospital chain operator reported a consolidated net profit of 3.9 billion rupees ($45.59 million)for January-March, compared to analysts' average expectation of 3.71 billion rupees, according to data compiled by LSEG. ($1 = 85.5410 Indian rupees)
Time of India
3 days ago
- Business
- Time of India
Apollo Hospitals Q4 Results: Cons PAT jumps 53% to Rs 390 crore; Rs 10/share dividend announced
Synopsis Apollo Hospitals Q4 Results: Apollo Hospitals Enterprise on Friday announced its Q4FY25 earnings where the company reported a net profit growth of 53.5% to Rs 390 crore versus Rs 254 crore in the year ago period. The profit is attributable to the owners of the company and has beaten Street's estimates of Rs 374 crore.
